Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients.
Simone de VriesMichael SchaapveldCécile P M JanusLaurien A DaniëlsEefke J PetersenRichard W M van der MaazenJosée M ZijlstraMax BeijertMarten R NijzielKarijn M S VerschuerenLeontien C M KremerAnna M van EggermondPieternella J LugtenburgAugustinus D G KrolJudith M RoesinkWouter J PlattelDick Johan van SpronsenGustaaf W van ImhoffJan Paul de BoerBerthe M P AlemanFlora E van LeeuwenPublished in: Journal of the National Cancer Institute (2022)
Compared with the general population, HL survivors have a substantially reduced life expectancy. Optimal selection of patients for primary CT is crucial, weighing risks of HL relapse and long-term toxicity.